Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Neoadjuvant Study of Chemotherapy Versus Endocrine Therapy in Postmenopausal Patients With Primary Breast Cancer

NCT00963729 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT00963729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00963729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Neoadjuvant Study of Chemotherapy Versus Endocrine Therapy in Postmenopausal Patients With Primary Breast Cancer
Lead sponsor
Imperial College London
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2008
Completion date
March 31, 2011
Enrollment
756 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer